Researcher Resources

NAF works with the most knowledgeable, accomplished Ataxia researchers in the world. We are committed to providing the resources needed to pursue a cure and better quality of life for people with Ataxia.

Research Grants

The National Ataxia Foundation is committed to funding the best science relevant to hereditary and sporadic types of ataxia in both basic and translational research. NAF invites research applications from U.S.A. and International non-profit and for-profit institutions. Non-U.S. citizens are eligible to apply for a research grant from NAF.
Funding for Ataxia-Telangiectasia research proposals will receive a lower priority unless they lend themselves to an overall better understanding of the ataxia disease process.
Funds provided by the National Ataxia Foundation may not be used for indirect/F&A costs.
You may contact Sue Hagen, NAF Research Services Director, at with questions.
Below are descriptions of NAF’s research programs:

NAF Research Grants

Grant instructions will be available by August 1, 2019

Research Seed Money Awards

Research Grant: One-year seed money grants of up to $15,000 but promising proposals up to a maximum of $30,000 will be considered for early or pilot phases of studies and ongoing investigations. Applicants for seed-money grants need to be faculty members.

Details and instructions for the National Ataxia Foundation’s research grant application program for funding for March 1, 2020-February 28, 2021 will be available on this site on August 1, 2019.

Deadlines for Letters of Intent and full applications are:

Seed Money Research Grants
Letter of Intent due 9/16/19
Applications due 10/15/19

Young Investigator Research Awards
Letter of Intent due 10/1/19
Applications due 11/1/19

Pioneer SCA Research Grants
Letter of Intent due 10/15/19
Applications due 11/15/19

Pioneer SCA Translational Research Awards

Pioneer SCA Award: One-year grants of $100,000. These grants are intended for established ataxia researchers. One Pioneer grant will be awarded for research in SCA3/MJD and one will be awarded for research in any SCA.

Young Investigator Awards

Young Investigator (YI) Award: One-year grants of $35,000 to encourage young investigators to pursue a career in the field of any form of Ataxia research.

Young Investigator (YI-SCA) Award: One-year grants of $50,000 to encourage young investigators to pursue a career in the field Spinocerebellar ataxia research. Two YI-SCA grants will be awarded.

For Young Investigator award programs, candidates must have attained an MD or PhD degree, and have an appointment as a junior faculty member, senior post-doc or clinical fellow. Individuals at the Associate Professor level are not eligible. Clinicians must have finished their residency no more than five years prior to applying. PhDs must be no more than five years from the end of the completion of their post-doc training.

The sponsoring institution must agree in writing to the following provision: the young investigator (MD or PhD) must be free to allocate approximately half time (50%) for Ataxia related research.

Fellowship Awards

Research Post-Doc Fellowship Award: One-year grants up to $35,000. Applicants should have completed at least one year of post-doctoral training, but not more than two at the time of application, and should have shown a commitment to research in the field of Ataxia.

Recruit Research Patients

Ataxia Patient Meeting

The National Ataxia Foundation hosts an annual patient meeting each year which is attended by those affected by Ataxia and their caregivers and family members. Attendance is often over 500 individuals. Presentations by leading Ataxia researchers and clinicians are given during the 3-day conference. Ataxia researchers are invited to participate in the exhibit area of the meeting to recruit patients for IRB approved research studies or share their research findings.

If you are interested in recruiting patients at the National Ataxia Foundation’s Annual Membership Meeting, please contact the National Ataxia Foundation at (763) 553-0020 or email

Access Patient Registry